Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 3, 2011, Pages 538-545

  Modhave, Dattatray T ^a   Handa, Tarun ^a   Shah, Ravi P ^a   Singh, Saranjit ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Characterization; Degradation mechanism; LC MS; Lornoxicam; Stress testing

Indexed keywords

LORNOXICAM;

ARTICLE; DRUG DEGRADATION; DRUG EXPOSURE; DRUG OXIDATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTHERMIC THERAPY; LIGHT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHOTOLYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOLID STATE; TEMPERATURE STRESS; TIME OF FLIGHT MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HYDROLYSIS; MASS SPECTROMETRY; OXIDATION-REDUCTION; PHOTOLYSIS; PIROXICAM; TECHNOLOGY, PHARMACEUTICAL;

EID: 79961129639     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.06.012     Document Type: Article

References (19)

1. Liu D.Q., Wu L., Sun M., MacGregor P.A. On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities. J. Pharm. Biomed. Anal. 2007, 44:320-329.
2. Shah R.P., Kumar V., Singh S. Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products. Rapid Commun. Mass Spectrom. 2008, 22:613-622.
3. Prasad B., Garg A., Takwani H., Singh S. Metabolite identification by liquid chromatography-mass spectrometry. Trends Anal. Chem. 2011, 30:360-387.
4. Petrovic M., Farré M., de Alda M.L., Perez S., Postigo C., Köck M., Radjenovic J., Gros M., Barceló D. Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples. J. Chromatogr. A 2010, 1217:4004-4017.
5. Picó Y., Barceló D. The expanding role of LC-MS in analyzing metabolites and degradation products of food contaminants. Trends Anal. Chem. 2008, 27:821-835.
6. Shah R.P., Singh S. Identification and characterization of a photolytic degradation product of telmisartan using LC-MS/TOF, LC-MSn, LC-NMR and on-line H/D exchange mass studies. J. Pharm. Biomed. Anal. 2010, 53:755-761.
7. Mehta S., Shah R.P., Priyadarshi R., Singh S. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil. J. Pharm. Biomed. Anal. 2010, 52:345-354.
8. Kumar V., Shah R.P., Malik S., Singh S. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation. J. Pharm. Biomed. Anal. 2009, 49:880-888.
9. Bhardwaj S.P., Singh S. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method. J. Pharm. Biomed. Anal. 2008, 46:113-120.
10. Mehta S., Shah R.P., Singh S. Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: application to valsartan, a model drug. Drug Test. Anal. 2010, 2:82-90.
11. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2006, 700-701. McGraw Hill Medical Publishing Division, New York. 11th edition. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
12. Vane J.R., Botting R.M. Mechanism of action of antiinflammatory drugs. Int. J. Tissue React. 1998, 20:3-15.
13. Rao R.N., Meena S., Rao A.R. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. J. Pharm. Biomed. Anal. 2005, 39:349-363.
14. Welte S.R., Dittrich P. Determination of the novel non-steroidal antiinflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J. Chromatogr. B 1998, 707:151-159.
15. Patil K.R., Rane V.P., Sangshetti J.N., Shinde D.B. Stability-indicating LC method for analysis of lornoxicam in the dosage form. Chromatographia 2009, 69:1001-1005.
16. ICH Photostability testing of new drug substances and products Q1B. International Conference on Harmonisation 1996, IFPMA, Geneva.
17. Bakshi M., Singh S. Guidance on conduct of stress tests to determine inherent stability of drugs. Pharm. Technol. 2000, 24:1-14.
18. March J. Advanced Organic Chemistry 2005, A Wiley-Interscience Publication, Singapore, pp. 383-383.
19. Bansal G., Singh M., Jindal K.C., Singh S. LC-UV-PDA and LC-MS studies on forced degradation behavior of glibenclamide and development of a stability-indicating method. J. AOAC Int. 2008, 91:709-719.